Seshadri Neervannan
2023
In 2023, Seshadri Neervannan earned a total compensation of $1.7M as Chief Operating Officer at Tarsus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $246,000 |
|---|---|
| Option Awards | $488,623 |
| Salary | $500,000 |
| Stock Awards | $494,095 |
| Other | $13,200 |
| Total | $1,741,918 |
Neervannan received $500K in salary, accounting for 29% of the total pay in 2023.
Neervannan also received $246K in non-equity incentive plan, $488.6K in option awards, $494.1K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Seshadri Neervannan's compensation ranked 640th out of 3,006 executives tracked by ExecPay. In other words, Neervannan earned more than 78.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 640 out of 3,006 | 79th |
Division Manufacturing | 357 out of 1,650 | 78th |
Major group Chemicals And Allied Products | 245 out of 918 | 73rd |
Industry group Drugs | 241 out of 881 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 81 out of 213 | 62nd |
Source: SEC filing on April 26, 2024.
Neervannan's colleagues
We found three more compensation records of executives who worked with Seshadri Neervannan at Tarsus Pharmaceuticals in 2023.